International Clinical Trial: A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117175) titled 'A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy' on Aug. 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Immunology Hematologic Malignancies CAR-NK

Intervention: Drug: Anti-human CD7 CAR-NK cell injection

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of F...